| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of hyperinsulinemic hypoglycemia related with a calcimimetic agent
|
Takashima, Satoru
|
|
2018
|
9 |
3 |
p. 196-200
|
artikel
|
| 2 |
Development of a novel estimation method for hemoglobin A1c using glycated albumin in type 2 diabetes mellitus patients with end-stage renal disease
|
Nakamura, Akihiko
|
|
2018
|
9 |
3 |
p. 179-188
|
artikel
|
| 3 |
Effect of switching from conventional continuous subcutaneous insulin infusion to sensor augmented pump therapy on glycemic profile in Japanese patients with type 1 diabetes
|
Matsuoka, Atsuko
|
|
2018
|
9 |
3 |
p. 201-207
|
artikel
|
| 4 |
Efficacy and safety of nateglinide plus sitagliptin combination therapy in type 2 diabetes patients inadequately controlled by sitagliptin monotherapy: a phase 3, multicenter, open-label, long-term study
|
Hirose, Takahisa
|
|
2018
|
9 |
3 |
p. 168-178
|
artikel
|
| 5 |
Factors involved in decreasing the therapeutic effect of sitagliptin: a subanalysis of the JAMP study
|
Nunome, Hideo
|
|
2017
|
9 |
3 |
p. 158-167
|
artikel
|
| 6 |
IAPP/amylin and β-cell failure: implication of the risk factors of type 2 diabetes
|
Kanatsuka, Azuma
|
|
2018
|
9 |
3 |
p. 143-157
|
artikel
|
| 7 |
Low body mass index and old age are useful in predicting the hemoglobin A1c-lowering effect of switching from sitagliptin to dulaglutide in Japanese patients with type 2 diabetes mellitus: a single-center, open-label, single-arm, pilot study
|
Iwasaki, Tomoyuki
|
|
2018
|
9 |
3 |
p. 189-195
|
artikel
|
Tijdschrift beschrijving